Safety and efficacy of sucroferric oxyhydroxide in pediatric patients with chronic kidney disease.

Larry A GreenbaumNikola JeckGünter KlausMarc FilaCristina StoicaSahar Fathallah-ShaykhAna ParedesLarysa WickmanRaoul NelsonRita D SwinfordCarolyn Larkins AbitbolMihaela BalgradeanAugustina JankauskienėAmandine PerrinMilica EnoiuSun-Young Ahn

Published in: Pediatric nephrology (Berlin, Germany) (2020)

SFOH effectively managed serum phosphorus in pediatric patients with a low pill burden and a safety profile consistent with that reported in adult patients.

Keyphrases

risk factors
risk assessment